… the prices of generic medicines in the US. Another … , Divi’s Laboratories, Cipla, Aurobindo Pharma, Lupin and Biocon—could … Pharma, along with hospital chains such as Apollo Hospitals, Fortis Healthcare … the affordability of generic drugs in the US. Industry …

(Reuters) -Indian drugmaker Aurobindo Pharma reported a lower first-quarter … patients. Among Aurobindo’s rivals, Cipla beat quarterly profit estimates, while … 10 0.96 1.12 Pharmaceuticals Ltd Zydus Lifesciences 21.39 … 0.96 1.13 Ltd Cipla Ltd 23.92 15.31 …

… presence. Companies such as Cipla, with flexible supply chains … US manufacturing by large pharmaceutical entities, particularly for active pharmaceutical ingredients (APIs), … challenges for the Indian pharmaceutical sector. Furthermore, the strategic …

… the near term. Nifty Pharma Index: Bearish signals emerge … this week, the Nifty Pharma Index came under sharp … such as Cipla, Lupin, Dr Reddy’s, Sun Pharma, Divi’s … Zydus Lifesciences, Torrent Pharma and Aurobindo Pharma. These collectively account for …

… were Sun Pharma, Dr. Reddy’s Laboratories, Adani Enterprises, and Cipla, all … losers on August 1 Sun Pharmaceutical closed at ₹1,629.3 … ,341.5, losing 3.7% Cipla closed at ₹1,505.0 …

… medication, Wegovy. The company plans to launch the drug … by extraordinary demand for medicines developed by Denmark-based … The company anticipates the drug will generate hundreds of … to Reuters. Indian pharmaceutical firms such as Cipla, Lupin, Biocon, …

… traded with losses. Pharma (down 3 per cent), healthcare, IT, oil … 50, while Sun Pharma, Dr Reddy’s Lab, Cipla, Tata Steel and … over 1 per cent. Aurobindo Pharma, Alkem, Page Industries, Glenmark … while PNB Housing, IIFL, Strides Pharma dragged 6-17 per cent …

… .35 at 12.45 pm. Pharmaceutical stocks emerged as the biggest … potential US trade restrictions. Sun Pharma led the losers on the … ₹1,218.10. Cipla also joined the pharma sell-off, dropping 3 …

… in the red. The Nifty Pharma index (-3.33%) was the … a 15% revenue growth. Sun Pharma was the biggest laggard on … closing 4.5% lower. The pharmaceutical company reported a 20% drop … crore for Q1FY26.  Other pharma stocks, including Cipla (-3.19%) and Dr …

… asked 17 global pharma giants to reduce drug prices in the … Nifty Pharma Index fell 2.45 percent, with major Indian drug … top global drug companies, asking them to reduce their medicine prices in … lost 3.2 percent Gland Pharma, Cipla, and Lupin were down 2 …